41.50
-1.63
(-3.78%)
As of 2:14:33 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 8 | 7 |
| Avg. Estimate | -0.28 | -0.21 | -0.72 | -0.01 |
| Low Estimate | -0.42 | -0.43 | -1.59 | -1.16 |
| High Estimate | -0.2 | -0.15 | -0.4 | 0.72 |
| Year Ago EPS | -- | -0.63 | -1.58 | -0.72 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 11 | 10 |
| Avg. Estimate | 248.9M | 298.99M | 1.24B | 1.54B |
| Low Estimate | 244.9M | 289.4M | 1.23B | 1.46B |
| High Estimate | 257.25M | 305M | 1.24B | 1.6B |
| Year Ago Sales | -- | 165.97M | 693.4M | 1.24B |
| Sales Growth (year/est) | -- | 80.15% | 78.38% | 24.88% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|
| EPS Est. | -1.79 | -0.28 | -0.15 |
| EPS Actual | -0.63 | -0.25 | -0.18 |
| Difference | 1.16 | 0.03 | -0.03 |
| Surprise % | 64.81% | 10.93% | -17.49% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.28 | -0.21 | -0.72 | -0.01 |
| 7 Days Ago | -0.26 | -0.18 | -0.71 | 0 |
| 30 Days Ago | -0.26 | -0.18 | -0.71 | 0 |
| 60 Days Ago | -0.24 | -0.14 | -0.51 | 0.34 |
| 90 Days Ago | -0.25 | -0.2 | -0.62 | 0.12 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 2 | 1 | 2 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TEM | -- | 66.25% | 54.68% | 98.96% |
| S&P 500 | 6.76% | 5.73% | 9.19% | 14.14% |
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 4/10/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 3/6/2025 |
| Maintains | Piper Sandler: Neutral to Neutral | 3/4/2025 |
| Maintains | B of A Securities: Neutral to Neutral | 3/3/2025 |
| Reiterates | Guggenheim: Buy to Buy | 2/25/2025 |
| Maintains | Needham: Buy to Buy | 2/25/2025 |
Related Tickers
DOCS Doximity, Inc.
52.94
+0.65%
SDGR Schrödinger, Inc.
24.32
-8.36%
TDOC Teladoc Health, Inc.
7.20
-0.62%
MSPR MSP Recovery, Inc.
2.3000
-18.73%
ICCT iCoreConnect Inc.
3.2000
-17.31%
CERT Certara, Inc.
13.64
-5.28%
WORX SCWorx Corp.
0.6180
-11.66%
GEHC GE HealthCare Technologies Inc.
62.77
-2.52%
TXG 10x Genomics, Inc.
8.03
-2.96%
BFRG Bullfrog AI Holdings, Inc.
1.6600
-7.26%